New drug aims to ease hidden pain after keyhole surgery
NCT ID NCT07525986
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called anrikefon for treating internal pain after laparoscopic (keyhole) surgery. It is given through a pump that lets patients control their own pain relief. The trial includes 140 adults having colorectal surgery. The goal is to see if anrikefon provides better pain control with fewer side effects than standard painkillers.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- anrikefon
- What this could lead to
- If it works, this could provide a better way to manage internal pain after laparoscopic surgery, reducing reliance on opioids and their side effects.
- What could go wrong
- This is a small, early-phase pilot study (140 people). The drug may not work better than existing options, or could have unexpected side effects. Results may not apply to all surgeries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 140 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2026
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Aged \>= 18 years but \< 75 years; 2. Scheduled to undergo elective laparoscopic colorectal surgery with an expected duration of \>=1 hour; 3. The incisional pain can be covered by the transversus abdominis plane block or rectus sheath block; yet patients still require postoperative patient-controlled intravenous analgesia. Exclusion Criteria: 1. Presence of preoperative cognitive impairment (Mini-Mental State Examination \[MMSE\] score \< 27), or inability to communicate due to language barrier; 2. Body mass index (BMI) \> 30 kg/m² or \< 18 kg/m²; 3. Presence of poorly controlled or untreated comorbidities, including but not limited to the following: hypertension characterized by a resting systolic blood pressure (SBP) \> 180 mmHg and/or diastolic blood pressure (DBP) \> 110 mmHg, coronary artery disease with unstable angina or myocardial infarction within 6 months, heart failure rated as New York Heart Association classification \>= III, severe chronic obstructive pulmonary disease (or in a state of acute exacerbation), severe hepatic insufficiency (Child-Pugh grade C), severe renal insufficiency (estimated glomerular filtration rate \< 30 ml/min/1.73m²), or American Society of Anesthesiologists (ASA) physical status classification \>= IV; 4. Continuous use of opioid analgesics for more than 10 days for any reason, or alcohol abuse (average daily intake of pure alcohol \> 36 g) within 3 months before screening; 5. Preoperative use of opioid or non-opioid analgesics with the interval between the last administration and randomization shorter than five half-lives of the drug or the duration of drug action (whichever is longer); 6. Known allergies or contraindications to opiates or other medications that may be used in this study, such as anesthetics, antiemetics, and nonsteroidal anti-inflammatory drugs (NSAIDs); 7. Anticipated need for postoperative mechanical ventilation; 8. Other conditions that are considered unsuitable for study participation.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anrikefon are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Peking University First Hospital
RECRUITINGBeijing, Beijing Municipality, 100034, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a routine surgical step prevent ureter injuries in hysterectomy?
- Can a new mesh implant fix pelvic organ prolapse better?
- New opioid aims to cut Post-Surgery nausea without sacrificing pain relief
- New monitoring method may keep seniors breathing easier after surgery
- Scientists test best way to combine two common anesthetics
- Could a simple injection before surgery cut Post-Op pain?